TY  - JOUR
AU  - Amat, T
AU  - Gutierrez-Pizarraya, A
AU  - Machuca, I
AU  - Gracia-Ahufinger, I
AU  - Perez-Nadales, E
AU  - Torre-Gimenez, A
AU  - Garnacho-Montero, J
AU  - Cisneros, J M
AU  - Torre-Cisneros, J
PY  - 2017
DO  - 10.1016/j.cmi.2017.09.016
UR  - http://hdl.handle.net/10668/11638
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - To assess the association of survival and treatment with colistin and tigecycline in critically ill patients with carbapenem-resistant Acinetobacter baumannii bacteraemia. An observational cohort study was carried out. Targeted therapy consisted of...
LA  - en
PB  - Elsevier
KW  - Acinetobacter baumannii
KW  - Bacteriemia
KW  - Carbapenem-resistant
KW  - Colistin
KW  - Tigecycline
KW  - Acinetobacter infections
KW  - Acinetobacter baumannii
KW  - Adult
KW  - Bacteremia
KW  - Carbapenems
KW  - Cohort studies
KW  - Colistin
KW  - Critical illness
KW  - Drug therapy, combination
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle aged
KW  - Minocycline
KW  - Propensity score
KW  - Survival analysis
KW  - Tigecycline
KW  - Treatment outcome
TI  - The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
TY  - research article
VL  - 24
ER  -